• Investors may be assessing whether Exelon at around US$44.41 is offering fair value today, or if the current price is mispricing the long term story.
• The stock has slipped 3.4% over the last 7 days and 9.5% over the last 30 days, while the 1 year return sits at 2.0% and the 5 year return at 65.7%.
• Recent attention on Exelon has centered on its role as a large regulated utility. Investors are watching how its business mix and capital plans fit into long term energy and grid needs. This backdrop helps frame how the recent share price moves may relate to shifts in sentiment about stability and future cash flows.
• Exelon currently has a valuation score of 3 out of 6. The rest of this article will walk through the main valuation approaches used to reach that figure, before finishing with a framework that can help you interpret those numbers more effectively.

Approach 1: Exelon Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes estimates of a company’s future cash flows and discounts them back to today using a required rate of return. The idea is to work out what those future dollars are worth in today’s terms.

For Exelon, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is a loss of $1,465.42m. Analysts provide forecasts out to 2028, with projected free cash flow of $292m in that year, and Simply Wall St then extrapolates further estimates through 2035 using those inputs as a guide.

Discounting this stream of future cash flows in dollar terms gives an estimated intrinsic value of $17.95 per share. Compared with a recent share price around $44.41, the model implies the stock is trading well above this estimate, with an intrinsic discount that points to around 147.4% overvaluation on this DCF view.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Exelon may be overvalued by 147.4%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Exelon Price vs Earnings

For a profitable company, the P/E ratio is a useful way to think about what you are paying for each dollar of earnings, which is often how the market anchors day to day pricing decisions.

In simple terms, higher growth expectations and lower perceived risk tend to justify a higher P/E multiple, while slower expected growth or higher risk usually go with a lower, more cautious multiple. So, there is no single “right” P/E; it depends on what the market expects from the company over time.

Exelon currently trades on a P/E of 16.35x, compared with an Electric Utilities industry average of about 21.65x and a peer group average around 21.24x. Simply Wall St also calculates a proprietary “Fair Ratio” of 23.63x for Exelon. This Fair Ratio is designed to be more tailored than a simple peer or industry comparison because it incorporates factors such as earnings growth, profit margins, risk profile, market capitalization and the company’s specific industry.

Comparing the Fair Ratio of 23.63x with the actual P/E of 16.35x suggests the stock is trading below this fair value benchmark on an earnings multiple basis.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Exelon Narrative

Earlier it was mentioned that there is an even better way to think about valuation, so Narratives are introduced here as simple stories you create about Exelon that connect your view of its future revenue, earnings and margins to a financial forecast, a fair value and then a clear comparison with the current price. This is done within an easy tool on Simply Wall St’s Community page that updates as news or earnings arrive and can look very different from investor to investor. For example, one Exelon Narrative might use the more optimistic fair value near US$58 and another might use the cautious end around US$43. This helps you decide whether the stock looks expensive or reasonable against your own fair value rather than relying only on static ratios.

Do you think there's more to the story for Exelon? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.